NRNP 6630 Final Exam
Question 1 II
1 out of 1 points
II II II II
What IIwill IIthe IIPMHNP IImost IIlikely IIprescribe IIto IIa IIpatient IIwith IIpsychotic IIaggression IIwho IIneeds IIto IImanage
II the IItop-down IIcortical IIcontrol IIand IIthe IIexcessive IIdrive IIfrom IIstriatal IIhyperactivity?
Selected Answer: C.
II II
Antipsychotics
• Question 2 II
1 out of 1 points
II II II II
The IIPMHNP IIis IIselecting IIa IImedication IItreatment IIoption IIfor IIa IIpatient IIwho IIis IIexhibiting IIpsychotic
IIbehaviors IIwith IIpoor IIimpulse IIcontrol IIand IIaggression. IIOf IIthe IIavailable IItreatments, IIwhich IIcan IIhelp IItemper
IIsome IIof IIthe IIadverse IIeffects IIor IIsymptoms IIthat IIare IInormally IIcaused IIby IID2 IIantagonism?
Selected Answer: D.
II II
Second -generation, IIatypical IIantipsychotics
• Question 3 II
1 out of 1 points
II II II II
The IIPMHNP IIis IIdiscussing IIdopamine IID2 IIreceptor IIoccupancy IIand IIits IIassociation IIwith IIaggressive IIbehaviors
II in IIpatients IIwith IIthe IIstudent. IIWhy IIdoes IIthe IIPMHNP IIprescribe IIa IIstandard IIdose IIof IIatypical IIantipsychotics?
Selected Answer: C.
II II
The doses are based on achieving 60% D2 receptor occupancy.
II II II II II II II II II
• Question 4 II
1 out of 1 points
II II II II
Why IIdoes IIthe IIPMHNP IIavoid IIprescribing IIclozapine II(Clozaril) IIas IIa IIfirst-line IItreatment IIto IIthe IIpatient IIwith
II psychosis IIand IIaggression?
, Selected Answer: A.
II II
There IIis IItoo IIhigh IIa IIrisk IIof IIserious IIadverse IIside IIeffects.
• Question 5 II
1 out of 1 points
II II II II
The IIPMHNP IIis IIcaring IIfor IIa IIpatient IIon IIrisperidone II(Risperdal). IIWhich IIaction IImade IIby IIthe IIPMHNP
II exhibits IIproper IIcare IIfor IIthis IIpatient? II</p?
Selected Answer: C.
II II
Titrating IIthe IIdose IIby IIincreasing IIit IIevery II5–7 IIdays
• Question 6 II
1 out of 1 points
II II II II
The IIPMHNP IIwants IIto IIprescribe IIMr. IIBarber IIa IImood IIstabilizer IIthat IIwill IItarget IIaggressive IIand IIimpulsive
IIsymptoms IIby IIdecreasing IIdopaminergic IIneurotransmission. IIWhich IImood IIstabilizer IIwill IIthe IIPMHNP IIselect?
Selected Answer: A.
II II
Lithium II(Lithane)
• Question 7 II
1 out of 1 points
II II II II
The IIparents IIof IIa II7-year-old IIpatient IIwith IIADHD IIare IIconcerned IIabout IIthe IIeffects IIof IIstimulants IIon IItheir
IIchild. IIThe IIparents IIprefer IIto IIstart IIpharmacological IItreatment IIwith IIa IInon-stimulant. IIWhich IImedication IIwill
IIthe IIPMHNP IIwill IImost IIlikely IIprescribe?
Selected Answer: A.
II II
Strattera
• Question 8 II
1 out of 1 points
II II II II
The IIPMHNP IIunderstands IIthat IIslow-dose IIextended IIrelease IIstimulants IIare IImost IIappropriate IIfor IIwhich
patient IIwith IIADHD?
II
Selected Answer: A.
II II
8 -year-old IIpatient
• Question 9 II
, 1 out of 1 points
II II II II
A IIpatient IIis IIprescribed IID-methylphenidate, II10-mg IIextended-release IIcapsules. IIWhat IIshould IIthe IIPMHNP
II include IIwhen IIdiscussing IIthe IIside IIeffects IIwith IIthe IIpatient? II II
Selected Answer: C.
II II
The IImedication IIcan IIaffect IIyour IIblood IIpressure.
• Question 10 II
1 out of 1 points
II II II II
The IIPMHNP IIis IIteaching IIparents IIabout IItheir IIchild’s IInew IIprescription IIfor IIRitalin. IIWhat IIwill IIthe IIPMHNP
II include IIin IIthe IIteaching? II
Selected Answer: A.
II II
The IIsecond IIdose IIshould IIbe IItaken IIat IIlunch.
• Question 11 II
1 out of 1 points
II II II II
A IIyoung IIpatient IIis IIprescribed IIVyvanse. IIDuring IIthe IIfollow-up IIappointment, IIwhich IIcomment IImade IIby IIthe
II patient IImakes IIthe IIPMHNP IIthink IIthat IIthe IIdosing IIis IIbeing IIdone IIincorrectly?
Selected Answer: B.
II II
“I IIam IIunable IIto IIfall IIasleep IIat IInight.”
• Question 12 II
1 out of 1 points
II II II II
A II14-year-old IIpatient IIis IIprescribed IIStrattera IIand IIasks IIwhen IIthe IImedicine IIshould IIbe IItaken. IIWhat IIdoes IIthe
II PMHNP IIunderstand IIregarding IIthe IIdrug’s IIdosing IIprofile?
Selected Answer: B.
II II
The IIpatient IIwill IIhave IIone IIor IItwo IIdoses IIa IIday.
• Question 13 II
0 out of 1 points
II II II II
The IIPMHNP IIis IImeeting IIwith IIthe IIparents IIof IIan II8-year-old IIpatient IIwho IIis IIreceiving IIan IIinitial IIprescription
IIfor IID-amphetamine. IIThe IIPMHNP IIdemonstrates IIappropriate IIprescribing IIpractices IIwhen IIshe IIprescribes IIthe
IIfollowing IIdose: II II
Selected Answer: D.
II II
Question 1 II
1 out of 1 points
II II II II
What IIwill IIthe IIPMHNP IImost IIlikely IIprescribe IIto IIa IIpatient IIwith IIpsychotic IIaggression IIwho IIneeds IIto IImanage
II the IItop-down IIcortical IIcontrol IIand IIthe IIexcessive IIdrive IIfrom IIstriatal IIhyperactivity?
Selected Answer: C.
II II
Antipsychotics
• Question 2 II
1 out of 1 points
II II II II
The IIPMHNP IIis IIselecting IIa IImedication IItreatment IIoption IIfor IIa IIpatient IIwho IIis IIexhibiting IIpsychotic
IIbehaviors IIwith IIpoor IIimpulse IIcontrol IIand IIaggression. IIOf IIthe IIavailable IItreatments, IIwhich IIcan IIhelp IItemper
IIsome IIof IIthe IIadverse IIeffects IIor IIsymptoms IIthat IIare IInormally IIcaused IIby IID2 IIantagonism?
Selected Answer: D.
II II
Second -generation, IIatypical IIantipsychotics
• Question 3 II
1 out of 1 points
II II II II
The IIPMHNP IIis IIdiscussing IIdopamine IID2 IIreceptor IIoccupancy IIand IIits IIassociation IIwith IIaggressive IIbehaviors
II in IIpatients IIwith IIthe IIstudent. IIWhy IIdoes IIthe IIPMHNP IIprescribe IIa IIstandard IIdose IIof IIatypical IIantipsychotics?
Selected Answer: C.
II II
The doses are based on achieving 60% D2 receptor occupancy.
II II II II II II II II II
• Question 4 II
1 out of 1 points
II II II II
Why IIdoes IIthe IIPMHNP IIavoid IIprescribing IIclozapine II(Clozaril) IIas IIa IIfirst-line IItreatment IIto IIthe IIpatient IIwith
II psychosis IIand IIaggression?
, Selected Answer: A.
II II
There IIis IItoo IIhigh IIa IIrisk IIof IIserious IIadverse IIside IIeffects.
• Question 5 II
1 out of 1 points
II II II II
The IIPMHNP IIis IIcaring IIfor IIa IIpatient IIon IIrisperidone II(Risperdal). IIWhich IIaction IImade IIby IIthe IIPMHNP
II exhibits IIproper IIcare IIfor IIthis IIpatient? II</p?
Selected Answer: C.
II II
Titrating IIthe IIdose IIby IIincreasing IIit IIevery II5–7 IIdays
• Question 6 II
1 out of 1 points
II II II II
The IIPMHNP IIwants IIto IIprescribe IIMr. IIBarber IIa IImood IIstabilizer IIthat IIwill IItarget IIaggressive IIand IIimpulsive
IIsymptoms IIby IIdecreasing IIdopaminergic IIneurotransmission. IIWhich IImood IIstabilizer IIwill IIthe IIPMHNP IIselect?
Selected Answer: A.
II II
Lithium II(Lithane)
• Question 7 II
1 out of 1 points
II II II II
The IIparents IIof IIa II7-year-old IIpatient IIwith IIADHD IIare IIconcerned IIabout IIthe IIeffects IIof IIstimulants IIon IItheir
IIchild. IIThe IIparents IIprefer IIto IIstart IIpharmacological IItreatment IIwith IIa IInon-stimulant. IIWhich IImedication IIwill
IIthe IIPMHNP IIwill IImost IIlikely IIprescribe?
Selected Answer: A.
II II
Strattera
• Question 8 II
1 out of 1 points
II II II II
The IIPMHNP IIunderstands IIthat IIslow-dose IIextended IIrelease IIstimulants IIare IImost IIappropriate IIfor IIwhich
patient IIwith IIADHD?
II
Selected Answer: A.
II II
8 -year-old IIpatient
• Question 9 II
, 1 out of 1 points
II II II II
A IIpatient IIis IIprescribed IID-methylphenidate, II10-mg IIextended-release IIcapsules. IIWhat IIshould IIthe IIPMHNP
II include IIwhen IIdiscussing IIthe IIside IIeffects IIwith IIthe IIpatient? II II
Selected Answer: C.
II II
The IImedication IIcan IIaffect IIyour IIblood IIpressure.
• Question 10 II
1 out of 1 points
II II II II
The IIPMHNP IIis IIteaching IIparents IIabout IItheir IIchild’s IInew IIprescription IIfor IIRitalin. IIWhat IIwill IIthe IIPMHNP
II include IIin IIthe IIteaching? II
Selected Answer: A.
II II
The IIsecond IIdose IIshould IIbe IItaken IIat IIlunch.
• Question 11 II
1 out of 1 points
II II II II
A IIyoung IIpatient IIis IIprescribed IIVyvanse. IIDuring IIthe IIfollow-up IIappointment, IIwhich IIcomment IImade IIby IIthe
II patient IImakes IIthe IIPMHNP IIthink IIthat IIthe IIdosing IIis IIbeing IIdone IIincorrectly?
Selected Answer: B.
II II
“I IIam IIunable IIto IIfall IIasleep IIat IInight.”
• Question 12 II
1 out of 1 points
II II II II
A II14-year-old IIpatient IIis IIprescribed IIStrattera IIand IIasks IIwhen IIthe IImedicine IIshould IIbe IItaken. IIWhat IIdoes IIthe
II PMHNP IIunderstand IIregarding IIthe IIdrug’s IIdosing IIprofile?
Selected Answer: B.
II II
The IIpatient IIwill IIhave IIone IIor IItwo IIdoses IIa IIday.
• Question 13 II
0 out of 1 points
II II II II
The IIPMHNP IIis IImeeting IIwith IIthe IIparents IIof IIan II8-year-old IIpatient IIwho IIis IIreceiving IIan IIinitial IIprescription
IIfor IID-amphetamine. IIThe IIPMHNP IIdemonstrates IIappropriate IIprescribing IIpractices IIwhen IIshe IIprescribes IIthe
IIfollowing IIdose: II II
Selected Answer: D.
II II
